Connect with us
Prague Gaming & TECH Summit 2024

Fintech PR

Antibiotics Market Size Worth $57.99 Billion By 2028 | CAGR: 4.5%: Grand View Research, Inc.

Published

on

 

The global antibiotics market size is expected to reach USD 57.99 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.5% from 2021 to 2028. High usage of antibiotics and inappropriate prescription behavior of antibiotic drugs worldwide are the major factors anticipated to drive the market. Moreover, rising awareness among patients and healthcare professionals and increasing involvement of regulatory bodies in the R&D activities of new therapies to treat infectious diseases are expected to propel the market growth over the forecast period.

Key suggestions from the report:

  • By action mechanism, the cell wall synthesis inhibitors segment accounted for the largest share of 52.1% in 2020 and is anticipated to maintain its lead over the forecast period
  • Based on drug class, the cephalosporin segment held the second-largest share in 2020. Pipeline candidates in cephalosporin drug class such as Fetroja (cefiderocol), cefilavancin, and ceftobiprole are anticipated to drive the segment in the forecast period
  • The others’ drug class segment is expected to grow at the fastest rate during the forecast period. The segment consists of various existing classes of antibiotics as well as some newly developed drugs, such as tetracycline, carbapenem, imidazole, peptides, lincosamides, and monoclonal antibodies
  • Asia Pacific was the largest regional market in 2020 and is expected to witness the fastest growth in the coming years owing to the rising consumption of antibiotics and high disease prevalence
  • North America emerged as the second-largest regional market in 2020 owing to government initiatives for the development of new therapies and better reimbursement scenario

Read 120 page research report with ToC on “Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA), By Action Mechanism, And Segment Forecasts, 2021 – 2028” at: https://www.grandviewresearch.com/industry-analysis/antibiotic-market

An increasing number of public-private collaborations, wherein funding and innovative R&D approaches are provided by public agencies to firms developing antibiotics, is expected to boost the product pipeline. For instance, in December 2018, Eisai Co., Ltd., and Takeda Pharmaceutical Company Limited announced an agreement with GARDP for the development of novel antibacterial compounds.

Betterment in the approval process of antibiotic drugs is expected to boost the market growth over the forecast period. In February 2020, Merck received acceptance for a review of supplemental New Drug Application (sNDA) from the U.S. FDA for RECARBRIO (imipenem, cilastatin, and relebactam) intended for HABP/VABP. This submission is anticipated to reinforce the continued dedication of the company to R&D pertaining to antibiotic therapies that address unmet medical needs.

Government reforms such as the Generating Antibiotics Incentives Now Act in the U.S. are projected to propel market growth in the coming years. This is further expected to facilitate the development process of advanced drugs. According to the Pew Charitable Trusts, about 30% of the outpatient oral antibiotic drug prescriptions are unnecessary and most of these prescriptions are for disease conditions against which antibiotics are not significantly effective, such as non-bacterial infections and acute respiratory conditions.

The market is highly competitive and major market players have almost similar market share. Pharmaceutical players are adopting strategies, including mergers & acquisitions, collaborations, and strategic alliances, to gain a competitive advantage. The major pharmaceutical companies are collaborating for developing novel therapies to reduce the cost burden of the drug development process. In December 2019, Appili Therapeutics signed an agreement with Saptalis Pharmaceuticals for the reformulation of antibiotic metronidazole. According to the agreement, Saptalis will be responsible for manufacturing, marketing of ATI-1501 in the United States. Moreover, in October 2018, Paratek Pharmaceuticals, Inc. entered into a license agreement for the development and commercialization of Seysara (sarecyline) with Allergan.

A group of key pharmaceutical players has launched AMR Action Fund worth USD 1 billion in July 2020. This fund is expected to support the research of innovative and novel antibiotics and is formed in collaboration with the European Investment Bank, the Wellcome Trust, and the World Health Organization.

Due to the lack of commercial success for newly developed antimicrobial drugs, government and non-government bodies have adopted strategies to incentivize antibiotic drug R&D activities. For instance, the government in alliance with BARDA is supporting several companies to boost the R&D activities in new therapies for infectious diseases. BARDA has also been associated with pharmaceutical companies, such as GSK, Tetraphase, and Basilea Astra Zeneca. CARB-X is investing around USD 109 million to support the early-stage development of potential therapeutic candidates.

Grand View Research has segmented the global antibiotics market on the basis of action mechanism, drug class, and region:

  • Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2017 – 2028)
    • Cell Wall Synthesis Inhibitors
    • Protein Synthesis Inhibitors
    • DNA Synthesis Inhibitors
    • RNA Synthesis Inhibitors
    • Mycolic Acid Inhibitors
    • Others
  • Antibiotics Drug Class Outlook (Revenue, USD Million, 2017 – 2028)
    • Cephalosporin
    • Penicillin
    • Fluoroquinolone
    • Macrolide
    • Carbapenem
    • Aminoglycoside
    • Sulfonamide
    • 7-ACA
    • Others
  • Antibiotics Regional Outlook (Revenue, USD Million, 2017 – 2028)
    • North America
      • U.S
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • India
      • China
      • Japan
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa

List of Key Players of Antibiotics Market

  • Merck & Co., Inc.
  • Allergan plc (AbbVie)
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Melinta Therapeutics
  • Basilea Pharmaceutica Ltd.
  • Tetraphase Pharmaceuticals
  • Paratek Pharmaceuticals, Inc.
  • Nabriva Therapeutics plc
  • Spero Therapeutics

Find more research reports on Pharmaceuticals Industry, by Grand View Research:

  • Monoclonal Antibodies Market  The global monoclonal antibodies market accounted for USD 85.4 billion in 2015 and is expected to exhibit a growth rate of 5.7% over the forecast period.
  • Animal Feed Additives Market  The global animal feed additives market size was USD 37.83 billion in 2019 and is projected to expand at a CAGR of 3.8% from 2020 to 2027.
  • Crohn’s Disease Therapeutics Market  The global Crohn’s disease therapeutics market size was estimated at USD 3.8 billion in 2016 and is expected to register a CAGR of 2.4% during the forecast period.

Fintech PR

World 50 Group Announces Winners for the 2024 I&D Impact Awards, Recognizing Workplace Excellence in Diversity, Equity, and Inclusion

Published

on

world-50-group-announces-winners-for-the-2024-i&d-impact-awards,-recognizing-workplace-excellence-in-diversity,-equity,-and-inclusion

ATLANTA, March 28, 2024 /PRNewswire/ — World 50 Group, the global community of business leaders from the most respected and influential companies, is delighted to announce the winners of the 2024 Inclusion & Diversity (I&D) Impact Awards. Now in its second year, the I&D Impact Awards spotlight the remarkable strides organizations have taken to create more equitable workplaces and communities around the world.

The winners were unveiled last night at the I&D Impact Awards ceremony in Miami, where hundreds of global executives from leading organizations gathered to celebrate outstanding achievements, advancements, and progress in DEI. Partners of the I&D Impact Awards, including Amazon, Best Buy, Cognizant, Joshin, RHR International, and SLB—all esteemed World 50 member companies and DEI champions—joined in the festivities.

“The 2024 I&D Impact Awards once again underscore the steadfast commitment of today’s leading companies to building a brighter future for us all,” said Jennifer Bird Newton, World 50’s chief impact officer. “We are in a pivotal moment for DEI. The significance of coming together to acknowledge our achievements—without resting on our laurels—cannot be overstated. Last night’s festivities served as a powerful reminder of the impact of collective action, and we extend heartfelt congratulations to this year’s winners.”

Chosen from a competitive pool of more than 140 entries from 74 unique organizations, the 2024 I&D Impact Awards winners represent leaders from diverse industries, spanning nine categories:

  • I&D Ally Award: Ferrero
  • Transparency Award, in partnership with Best Buy: Rio Tinto
  • Innovation Award, in partnership with Amazon: Victoria’s Secret & Co.
  • Gender Equality Award: Kimberly-Clark
  • I&D Team of the Year, in partnership with Cognizant: Inizio Evoke
    • Highly commended: Humana
  • I&D Leader of the Year, in partnership with RHR International: Lydia Smith, Chief Diversity Officer, Victoria’s Secret & Co.
    • Highly commended: Sherri Neal, Chief Diversity Officer, HCA Healthcare
  • Community Impact Award: Amazon
  • Inclusion Award, in partnership with Joshin: EY
    • Highly commended: Union Pacific
  • I&D Impact Award, in partnership with SLB: Cummins
    • Highly commended: Cargill

The winners were meticulously chosen by a panel of esteemed, independent judges comprising 24 top DEI executives from leading organizations, including AstraZeneca, Discover, Cognizant, Hilton, Lenovo, Mars, MetLife, and Warner Bros. Discovery, among others.

“Witnessing the passion, creativity, and impact of these winning initiatives reignites my belief in the power of inclusion to reshape our future,” said Crystal Andrew Banks, global head of diversity, equity, inclusion, and belonging at The Kraft Heinz Company. “Bravo to all companies that submitted a nomination, and let’s keep pushing boundaries together.”

Earl Newsome, chief information officer at Cummins, added: “Each submission showcased the beauty of creating diverse, equitable, and inclusive workplaces. Every entrant should take pride in the impact they are making.”

The I&D Impact Awards serve as a cornerstone of the World 50 I&D Impact Community, one of the largest groups of global DEI leaders in the world. Members convene regularly to exchange best practices and amplify what works when advancing DEI initiatives across the organization. Participation is complimentary for heads of DEI at World 50 member companies.

Learn more about the World 50 I&D Impact Awards—and how to get involved in 2025—here.

About World 50 Group
Leaders of the world’s most respected companies join World 50 to learn from one another. More than 4,800 global CEOs, board directors, and senior executives across every function—from 40 countries across six continents—trust the World 50 community for insights that deliver impact at scale.

World 50 is the safe space to exchange ideas, navigate complex challenges, and evolve as a leader. Members are at the forefront of transformation, leading organizations with a total market cap exceeding $34 trillion and more than 37 million employees worldwide.

To learn more about membership and request an invitation, visit world50.com.

World Fifty Group Logo

Photo – https://mma.prnewswire.com/media/2374546/0N5A5635.jpg

Logo – https://mma.prnewswire.com/media/2160049/World_Fifty_Group_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/world-50-group-announces-winners-for-the-2024-id-impact-awards-recognizing-workplace-excellence-in-diversity-equity-and-inclusion-302102831.html

Continue Reading

Fintech PR

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.

Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.

“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”

“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”

For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  

About ICIS

ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.

Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.

ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.

About RELX

RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.

Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Fintech PR

Bybit Web3 Announces “Mantle Sharding With Ethena” Campaign

Published

on

bybit-web3-announces-“mantle-sharding-with-ethena”-campaign

DUBAI, UAE, March 28, 2024 /PRNewswire/ — Bybit, one of the world’s top three crypto exchanges by volume, is thrilled to announce a campaign in collaboration with Mantle Network: Mantle Sharding With Ethena. This exciting event offers $MNT holders the opportunity to earn a share of a massive 2.5 billion Ethena Shards.

Lock In $MNT and Earn mShards

The official lock-in period for the Mantle Sharding With Ethena campaign runs from March 27, 2024, 10:00 AM UTC to April 26, 2024, 10:00 AM UTC. During this time, Bybit Web3 users can lock in their $MNT tokens to earn coveted mShards. These mShards, fully backed by the Mantle Treasury, can be later redeemed for Ethena’s native token, $ENA.

Maximize Your Rewards and Trade mShards Across DeFi dApps

For maximum reward potential, users are encouraged to keep their $MNT locked throughout the entire campaign period. Rewards are dynamically calculated and updated in real-time based on the total amount of $MNT locked per second by all participants.

Bybit Web3 is proud to be the first ecosystem to enable the trading of Ethena Shards in the form of mShards across various DeFi dApps. This integration marks a significant milestone for Mantle Ecosystem, paving the way for further exciting developments.

Don’t miss this opportunity to earn substantial rewards and contribute to the growth of the Mantle and Ethena ecosystems. For full details and participation instructions, please visit:

https://announcements.bybit.com/en/article/limited-time-offer-lock-in-mnt-and-grab-your-share-of-2-500-000-000-ethena-shards–blt66c8da8bd86d0910/

#Bybit / #TheCryptoArk / #BybitWeb3

About Bybit Web3

Bybit Web3 is redefining openness in the decentralized world, creating a simpler, open, and equal ecosystem for everyone. We are committed to welcoming builders, creators, and partners in the blockchain space, extending an invitation to both crypto enthusiasts and the curious, with a community of over 1 million wallet users, over 10 major ecosystem partners, and counting. 

Bybit Web3 provides a comprehensive suite of Web3 products designed to make accessing, swapping, collecting and growing Web3 assets as open and simple as possible. Our wallets, marketplaces and platforms are all backed by the security and expertise that define Bybit as a top 3 global crypto exchange, trusted by 25 million users globally.

Join the revolution now and open the door to your Web3 future with Bybit.

For more details about Bybit, please visit Bybit Web3.

About Bybit

Bybit is one of the world’s top three crypto exchanges by trading volume with 25 million users. Established in 2018, it offers a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press.

For media inquiries, please contact: [email protected]

For more information, please visit: https://www.bybit.com

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Logo – https://mma.prnewswire.com/media/2311075/Bybit_Web3_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/bybit-web3-announces-mantle-sharding-with-ethena-campaign-302102766.html

Continue Reading

Trending